White House launches health IT initiatives

Innovation Exchanges for Health IT, an initiative from the White House Startup America Initiative in partnership with the Department of Health and Human Services (HHS), has announced its several upcoming events.

Led by the Office of the Chief Technology Officer and the Office of the National Coordinator for Health IT (ONC), as part of the Investing in Innovations program, the Innovation Exchanges for Health IT are special forums bringing innovators and healthcare organizations together in order to find potential testing opportunities.

Wil Yu, special assistant at the ONC, posted Sept. 2 on a HealthITBuzz blog that more events, following the Philadelphia event that took place this May, will be held in:
  • Indianapolis (Oct. 12)
  • San Francisco (Sept. 25-27)
  • New England (October).

The administration is encouraging coordinated exchanges that may lead to potential collaborations—mutually beneficial to both early stage innovators and technology adopters. These events allow care organizations to evaluate, on a trial basis, the potential of new technologies they may be interested in piloting. Simultaneously, the events allow innovators to meet potential hosts for technological research and development—an important aspect to the innovation timeline.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.